NCT00349635

A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.

A Double-Blind, 3-Arm Study on Weight Loss With a Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Per Day Compared to Metformin 1,700 mg and to Placebo, at 6 Months, in Obese Patients, Followed by: A Double-Blind, 2-Arm Investigation of Weight-Loss Maintenance With the Same Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Compared to Placebo, at 6 Months, in the Responders.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 148 (planned)
• Sponsor: Solvay Pharmaceuticals · Industry
• Sex: All
• Age: 30 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.

Conditions

• Obesity

Interventions

Type	Name	Description
DRUG	Metformin and Metformin + Fenofibrate

Timeline

• Start date: 2004-10-01
• First posted: 2006-07-07
• Last updated: 2007-09-03

Locations

3 sites across 1 country: Finland